Symptom Clusters in Children With Leukemia
NCT01708421 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 338
Last updated 2018-11-06
Summary
The purpose of this study is to examine the phenotypic and genotypic characteristics and their associations with symptom clusters experienced during treatment for childhood leukemia.
Conditions
- Childhood Leukemia
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Marilyn Hockenberyy, PhD · Duke University School of Nursing
Eligibility
- Min Age
- 3 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-11-30
- Primary Completion
- 2018-08-01
- Completion
- 2018-08-01
Countries
- United States
Study Locations
More Related Trials
-
Examining a Training Program for for Acute Lymphoblastic Leukemia Childhood Cancer Survivors
NCT05086354 ·Status: COMPLETED ·Phase: NA
-
Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia
NCT00002816 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Brain Changes in ALL Patients on Therapy
NCT04767152 ·Status: RECRUITING ·Phase: NA
-
Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma
NCT00091091 ·Status: COMPLETED
-
Evaluating Supportive Care for Children With Cancer: A Multi-Institutional Survey Study of Pediatric Oncology Patients and Parents
NCT01273194 ·Status: COMPLETED
-
High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma
NCT03178617 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Treatment of Acute Lymphoblastic Leukemia in Children
NCT00165178 ·Status: COMPLETED ·Phase: PHASE3
-
Financial Distress During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States
NCT04928599 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia
NCT02303821 ·Status: COMPLETED ·Phase: PHASE1
-
Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
NCT00006462 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
NCT00003735 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
NCT00002812 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics of Drugs Administered to Children
NCT03481881 ·Status: RECRUITING
-
Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia
NCT00002704 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
NCT00005585 ·Status: COMPLETED ·Phase: PHASE3
-
A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With Leukemia
NCT00001689 ·Status: COMPLETED ·Phase: PHASE1
-
Chemotherapy Efficacy and Follow-up Study of Hepatitis B Virus Infection and Reactivation in Children With Leukemia
NCT03529760 ·Status: UNKNOWN
-
Home Chemotherapy Intervention for Children With Cancer - a Feasibility Study
NCT05372536 ·Status: COMPLETED ·Phase: NA
-
Advanced Translational Research on Childhood Leukemia
NCT04478006 ·Status: RECRUITING
-
Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous Leukemia
NCT00017342 ·Status: COMPLETED ·Phase: PHASE2
-
Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors
NCT00624962 ·Status: WITHDRAWN ·Phase: NA
-
Genetic Polymorphisms in Drug Induced Neuropathy in Children With ALL
NCT05811910 ·Status: UNKNOWN
-
Evaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer
NCT00897871 ·Status: UNKNOWN
-
Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors
NCT00003073 ·Status: UNKNOWN ·Phase: PHASE1
-
A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood Cancer
NCT02256137 ·Status: ACTIVE_NOT_RECRUITING